Additionally, the inhibition of PDE7B enhances the sensitivity of breast cancer cells to certain chemotherapeutic agents, such as microtubule-targeting drugs, thereby improving the effectiveness of chemotherapy (31). This evidence concerns the gene PDE7B and breast carcinoma.